review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jo Caers | Q40481275 |
Victor L Thijssen | Q51942278 | ||
Arjan W Griffioen | Q90910630 | ||
P2093 | author name string | Roy Heusschen | |
P2860 | cites work | Glycans in cancer and inflammation--potential for therapeutics and diagnostics | Q36148438 |
Inhibition of galectins with small molecules. | Q37862170 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systematic review | Q1504425 |
cancer diagnosis | Q110324059 | ||
P304 | page(s) | 235-247 | |
P577 | publication date | 2015-03-25 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Galectin expression in cancer diagnosis and prognosis: A systematic review | |
P478 | volume | 1855 |
Q38642366 | A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface. |
Q38779512 | A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies. |
Q37197649 | Antitumor effects of galectin-3 inhibition in human renal carcinoma cells |
Q36399256 | Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression |
Q92224022 | Blocking extracellular Galectin-3 in patients with osteoarthritis |
Q36381518 | Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers. |
Q33629970 | Cancer metastasis: enactment of the script for human reproductive drama |
Q37376365 | Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine. |
Q39231697 | Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation |
Q64945372 | Clinical significance of galectin-3 expression in malformed hepatic venous tissue. |
Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
Q39303610 | Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases. |
Q47162105 | E-cadherin dynamics is regulated by galectin-7 at epithelial cell surface. |
Q49667627 | Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy |
Q38809772 | Emerging Opportunities and Challenges in Cancer Immunotherapy. |
Q51558651 | Extracellular stress stimuli alter galectin expression profiles and adhesion characteristics of HL-60 cells. |
Q37284860 | Functional Characteristics of the Gut Microbiome in C57BL/6 Mice Differentially Susceptible to Plasmodium yoelii |
Q47117864 | Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes |
Q48270428 | Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives |
Q38763827 | Galectin-1 inhibitors and their potential therapeutic applications: a patent review |
Q38764048 | Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo |
Q35661292 | Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer |
Q26744513 | Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments |
Q47190193 | Galectin-3 and Cancer Stemness. |
Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
Q51731302 | Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy. |
Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
Q49203707 | Galectin-7 in Epithelial Homeostasis and Carcinomas |
Q47234461 | Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in MDCK cells. |
Q92408697 | Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model |
Q92303683 | Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation |
Q38942909 | Galectin-9: From cell biology to complex disease dynamics |
Q47438594 | Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas |
Q55316400 | Galectins as Molecular Targets for Therapeutic Intervention. |
Q38569702 | Glycosylation in cancer: mechanisms and clinical implications |
Q54980119 | Haliotis discus discus Sialic Acid-Binding Lectin Reduces the Oncolytic Vaccinia Virus Induced Toxicity in a Glioblastoma Mouse Model. |
Q91957003 | High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS |
Q47601253 | How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair |
Q26775999 | How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity |
Q89884673 | Impact of proteomics investigations on gastric cancer treatment and diagnosis |
Q40979079 | Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma |
Q64108089 | Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts |
Q59810310 | Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma |
Q88702132 | Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3 |
Q90399172 | Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes |
Q90333296 | Non-classical role of Galectin-3 in cancer progression: Translocation to nucleus by carbohydrate-recognition independent manner |
Q92837644 | Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo |
Q41295426 | Pingyangmycin Pretreatment Influences the Biological Behavior of Ocular Venous Malformation and Relates with Galectin-3 Expression |
Q91935820 | Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis |
Q53431665 | RETRACTED: Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. |
Q48124343 | Role of Galectins in Tumors and in Clinical Immunotherapy |
Q47108427 | Role of galectins in lung cancer |
Q36098356 | SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling |
Q49395392 | Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice. |
Q92358241 | Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis |
Q91176710 | Single-cell protein profiling in microchambers with barcoded beads |
Q37517611 | Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer. |
Q28075523 | The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1 |
Q33705268 | The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future |
Q26748606 | The emerging roles of exosomes in leukemogeneis |
Q42378844 | Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers |
Q38561302 | Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions. |
Q90598650 | Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination |
Q40984224 | Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3. |
Q36002404 | What gastric cancer proteomic studies show about gastric carcinogenesis? |
Search more.